Technology
VivoSense, which develops wearable biometric sensors to collect and organize data from patients for clinical drug trials, raises a $25M Series A (Keerthi Vedantam/dot.LA)
[ad_1]
[ad_2]
Keerthi Vedantam / dot.LA:
VivoSense, which develops wearable biometric sensors to collect and organize data from patients for clinical drug trials, raises a $25M Series A — As the CEO of Sarepta Therapeutics from 2011 to 2015, Chris Garabedian led a biotech firm striving to find cures for rare diseases.
[ad_2]
Share this news on your Fb,Twitter and Whatsapp
Times News Network:Latest News Headlines
Times News Network||Health||New York||USA News||Technology||World News